Chroni E.
- Country
- Greece
- Department
- Neurology Department, Neuromuscular Diseases section
Research Overview
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Iptacopan in Patients with Generalized Myasthenia Gravis
- Randomized, Quadruple-Blind, Placebo-Controlled Phase 2b Study of Batoclimab in Adults with Active Chronic Inflammatory Demyelinating Polyneuropathy
- Efficacy and Safety of Masitinib Plus Riluzole Versus Placebo Plus Riluzole in Amyotrophic Lateral Sclerosis: A Phase 3 Randomized Controlled Trial
Data & Insights
Has run more than one trial at 74 of 182 partner sites.
Specializations
Neuromuscular Disorders
This investigator specializes in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), conducting innovative therapeutic research with novel agents like batoclimab and nipocalimab for managing this chronic condition.
- CIDP treatment optimization
- Immunoglobulin therapy assessment
- Long-term disease management
The research extends to evaluating maintenance therapies and clinical response patterns in CIDP patients.
Neurological Diseases
Focused on advancing treatment options for Amyotrophic Lateral Sclerosis (ALS), the investigator explores combination therapies including masitinib with riluzole to enhance therapeutic outcomes.
- ALS treatment development
- Combination therapy assessment
- Disease progression management
The research aims to improve therapeutic approaches for ALS patients through innovative treatment combinations.
Autoimmune Disorders
Expertise in treating various forms of Myasthenia Gravis, including both ocular and generalized presentations, using novel therapeutic agents such as efgartigimod PH20 SC and iptacopan.
- Ocular Myasthenia Gravis treatment
- Generalized MG management
- Daily living function improvement
The research focuses on developing targeted therapies for different manifestations of Myasthenia Gravis.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.